PATENT CLAIM ANALYSIS

Application Number: 16011809
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "093700"]

Abstract:
Described herein are methods and compositions related to induced alveolar epithelial type 2 cells (iAEC2s), e.g., artificially-produced epithelial type 2 cells.

Claim (Index 4):
The method of  claim 1 , further comprising a culturing step after the contacting step, wherein the cells are cultured without being contacted with an agonist of Wnt/beta-catenin signaling.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 94.0
- Lexical Diversity: 1.2381
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15865574', '15902614', '15223603', '15134498', '14417273']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7617954460803946
- 35 USC 102 Novelty (BERT): 0.5750317261350449
- Combined Prediction Score: 0.7431190740858596
- Mean Citation Score: 416.1481700000001
- Max Citation Score: 554.1659999999998
- Similarity Product: 363.368742629528

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test